Data, tools and services options designed for life sciences

Life sciences organizations must substantiate the need for and value of their treatments to healthcare providers, payers and patients — and this requires integrated, patient-level evidence that spans the continuum of care.

IBM® MarketScan® Research Databases can help by providing one of the longest-running and largest collections of proprietary privately and publicly insured, de-identified claims data in the US. 

  • De-identified medical, drug, and dental claims for more than 265 million patients
  • Laboratory results
  • Productivity data — workplace absence, short- and long-term disability, and workers’ compensation
  • Health risk assessments (HRA)
  • Hospital discharges
  • Electronic medical records (EMR) 

You can gain insights from this data in the formats that work best for your organization — including licensing proprietary data with or without IBM integrated analytic tools and working with the IBM services team. These options can help you efficiently and confidently demonstrate the clinical and commercial value and viability of your treatments. 

Read the new MarketScan white paper →

Woman looking to a computer with a book and her hands

Products and services

Databases and data sets

Get details

Three core claims databases, a hospital discharge database and an EHR database. Linked databases, data sets and files combine claims with other data.

Analytic tools

Get details

Cloud-based software — no programming skills required — to cut research time, map treatments and estimate market sizes and opportunities.


Get details

Health economics and outcomes research to gain insights from real-world evidence using global data, rigorous design and advanced methodologies.

Analyzing cost offsets

Use case: Researchers compared real-world cost data from the MarketScan Databases for two different prescription therapies
for depression: selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs). 

Findings: Data showed that the two-year average cost of the TCAs was lower, but the overall cost of treatment for patients using TCAs was higher.

A man sit looking to a computer screen
A nurse collecting a sample

Quantifying vaccine outcomes

Use case: CDC researchers used the MarketScan Databases to conduct a retrospective, population-based study on the impact of the varicella (chickenpox) vaccine.

Findings: Data showed that hospitalizations declined by 88 percent and ambulatory visits by 59 percent from 1994 to 2002. Estimated direct medical expenditures declined by 74 percent — a savings of USD 62.8 million.

Evaluating economic costs

Use case: Researchers leveraged MarketScan HRA and Health and Productivity Management (HPM) Databases to quantify the economic implications of obesity in the US. 

Findings: Analysis of patient-level direct and indirect costs from claims and HPM data showed that severely obese patients had higher overall healthcare costs and lost more work time than normal weight individuals.

A woman in a market choosing food can
3 medicines in a table

Estimating indirect costs

Use case: Researchers examined the association between non-adherence to bipolar medications and lost productivity. 

Findings: Data showed that only 35.3 percent of patients adhered to their medication, and that non-adherent patients had higher adjusted indirect costs. Hypothetically, an employer could save USD 578,378 if all employee patients who were prescribed a bipolar medication adhered to their treatments.


Simplify research and analysis

A single source of patient-level information from over 265 million unique patients makes information easier to access and analyze. Getting different data types, tools, and services from a single vendor can help save time and effort.

Explore real-world costs

Information covers complete episodes from physician visits to carve-out care, such as mental health services. It reflects real-world costs — including indirect costs — to help conduct more inclusive and accurate cost and treatment studies.

Expand and enhance research

Linked data — including hospital discharge, EMR, claims, absenteeism, disability and workers’ compensation — can help you expand research in disease areas, incorporate drug therapies, analyze relationships with oral health and more.

Develop customized insights

Deep proprietary data from multiple care settings can be analyzed with our intuitive, self-service tools and/or by our team of data scientists, enabling you to develop insights customized to address your unique research requirements.

Broaden scope and improve accuracy

Robust, high-quality coding data such as fully paid and adjudicated claims, complete payment or charge information and complete outpatient services and prescription drug information can help increase the scope and accuracy of your research.

Follow data across health plans

Because the MarketScan Databases are derived from multiple sources — employers, managed care organizations, hospitals and Medicare/Medicaid — they continue tracking patient-level data even if individuals switch health plans.

Research unique patient populations

In the most recent full year, the MarketScan Databases include over 36.4 million patients with employer-provided health insurance. This coverage can help you achieve highly specific patient segmentation without sacrificing sample size.

Rely on a trusted partner

Cited in more than 2,400 peer-reviewed studies and journals, the data sets offer the quality, detail and reliability to support research conducted by life sciences, government, and academic organizations.

Get started, today.

One of the best ways to start building a strong research foundation is to schedule a consultation with an IBM representative who can… 

  • Answer initial questions and provide more background and details about MarketScan data, analytic tools and services
  • Determine the scope of your project as it relates to MarketScan products and services
  • Make recommendations about which data sets best fit your needs
  • Refine options based on your budget and time frame